Ä¢¹½ÊÓƵ

MITSUBISHI CHEMICAL GROUP
MITSUBISHI CHEMICAL GROUP

New launch of Mounjaro® 2.5 mg / 5 mg Ateos®, the world¡¯s first sustained release GIP/GLP-1 receptor agonist

April 18, 2023

Mitsubishi Tanabe Pharma Corporation, a member of the Ä¢¹½ÊÓƵ, has announced the following press release.

¡öMitsubishi Tanabe Pharma¡¡Press Release
New launch of Mounjaro® 2.5 mg / 5 mg Ateos®, the world’s first sustained release GIP/GLP-1 receptor agonist 

?Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top